282 related articles for article (PubMed ID: 26344547)
1. Network structure of brain atrophy in de novo Parkinson's disease.
Zeighami Y; Ulla M; Iturria-Medina Y; Dadar M; Zhang Y; Larcher KM; Fonov V; Evans AC; Collins DL; Dagher A
Elife; 2015 Sep; 4():. PubMed ID: 26344547
[TBL] [Abstract][Full Text] [Related]
2. A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.
Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Mišić B; Dagher A
Neuroimage; 2019 Apr; 190():69-78. PubMed ID: 29277406
[TBL] [Abstract][Full Text] [Related]
3. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
4. Basal ganglia atrophy-associated causal structural network degeneration in Parkinson's disease.
Li R; Zou T; Wang X; Wang H; Hu X; Xie F; Meng L; Chen H
Hum Brain Mapp; 2022 Feb; 43(3):1145-1156. PubMed ID: 34792836
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
6. Regional changes of brain structure during progression of idiopathic Parkinson's disease - A longitudinal study using deformation based morphometry.
Pieperhoff P; Südmeyer M; Dinkelbach L; Hartmann CJ; Ferrea S; Moldovan AS; Minnerop M; Diaz-Pier S; Schnitzler A; Amunts K
Cortex; 2022 Jun; 151():188-210. PubMed ID: 35439717
[TBL] [Abstract][Full Text] [Related]
7. Sex effects on brain structure in de novo Parkinson's disease: a multimodal neuroimaging study.
Tremblay C; Abbasi N; Zeighami Y; Yau Y; Dadar M; Rahayel S; Dagher A
Brain; 2020 Oct; 143(10):3052-3066. PubMed ID: 32980872
[TBL] [Abstract][Full Text] [Related]
8. Distinct functional and macrostructural brain changes in Parkinson's disease and multiple system atrophy.
Planetta PJ; Kurani AS; Shukla P; Prodoehl J; Corcos DM; Comella CL; McFarland NR; Okun MS; Vaillancourt DE
Hum Brain Mapp; 2015 Mar; 36(3):1165-79. PubMed ID: 25413603
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
Geng DY; Li YX; Zee CS
Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
[TBL] [Abstract][Full Text] [Related]
10. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
11. Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.
Ye BS; Jeon S; Yoon S; Kang SW; Baik K; Lee Y; Chung SJ; Oh JS; Moon H; Kim JS; Lee PH; Sohn YH
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):197-204. PubMed ID: 28951497
[TBL] [Abstract][Full Text] [Related]
12. Regional transcriptional architecture of Parkinson's disease pathogenesis and network spread.
Freeze B; Pandya S; Zeighami Y; Raj A
Brain; 2019 Oct; 142(10):3072-3085. PubMed ID: 31359041
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
[TBL] [Abstract][Full Text] [Related]
14. Brain structural and functional connectivity in Parkinson's disease with freezing of gait.
Canu E; Agosta F; Sarasso E; Volontè MA; Basaia S; Stojkovic T; Stefanova E; Comi G; Falini A; Kostic VS; Gatti R; Filippi M
Hum Brain Mapp; 2015 Dec; 36(12):5064-78. PubMed ID: 26359798
[TBL] [Abstract][Full Text] [Related]
15. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
Goldman JG; Stebbins GT; Dinh V; Bernard B; Merkitch D; deToledo-Morrell L; Goetz CG
Brain; 2014 Mar; 137(Pt 3):849-59. PubMed ID: 24480486
[TBL] [Abstract][Full Text] [Related]
16. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.
Labrador-Espinosa MA; Silva-Rodríguez J; Reina-Castillo MI; Mir P; Grothe MJ
Mov Disord; 2023 Oct; 38(10):1871-1880. PubMed ID: 37492892
[TBL] [Abstract][Full Text] [Related]
17. White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.
Dadar M; Zeighami Y; Yau Y; Fereshtehnejad SM; Maranzano J; Postuma RB; Dagher A; Collins DL
Neuroimage Clin; 2018; 20():892-900. PubMed ID: 30292088
[TBL] [Abstract][Full Text] [Related]
18. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
[TBL] [Abstract][Full Text] [Related]
19. Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis.
Uribe C; Segura B; Baggio HC; Abos A; Garcia-Diaz AI; Campabadal A; Marti MJ; Valldeoriola F; Compta Y; Tolosa E; Junque C
Parkinsonism Relat Disord; 2018 May; 50():3-9. PubMed ID: 29449187
[TBL] [Abstract][Full Text] [Related]
20. Patterns of cortical thinning in nondemented Parkinson's disease patients.
Uribe C; Segura B; Baggio HC; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Mov Disord; 2016 May; 31(5):699-708. PubMed ID: 27094093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
